Search

Author/Creator Shi, Genming

1. 344 Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2). (25th January 2023)

Authors:
Yosipovitch, Gil; Kwatra, Shawn G; Mollanazar, Nicholas; Ständer, Sonja; Satoh, Takahiro; Laws, Elizabeth; Mannent, Leda P; Mortensen, Eric; Maloney, Jennifer; Shi, Genming; Bansal, Ashish; Martinčová, Renata
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Lescure, François-Xavier; Honda, Hitoshi; Fowler, Robert A; Lazar, Jennifer Sloane; Shi, Genming; Wung, Peter; Patel, Naimish; Hagino, Owen; Bazzalo, Ignacio J.; Casas, Marcelo M.; Nuñez, Sebastián A.; Pere, Yael; Ibarrola, Carlos M.; Solis Aramayo, Marco A.; Cuesta, Maria C.; Duarte, Andrea E.; ...
Journal:
Lancet
Issue:
Volume 9:Issue 5(2021)
Page Start:
522
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗